By contributing within the VEGF/VEGFR2 signaling route, P53 alterations, cell cycle, and PI3K–Akt signaling system, S100A16 may influence the biological processes of RCC, resulting in varied prognoses. The gene discussed is S100A16; the disease is renal cell adenocarcinoma.